Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
2
pubmed:dateCreated
2011-7-18
pubmed:abstractText
The aim of this retrospective study was to assess the incidence of late complications occurring ?2 years after allogeneic hematopoietic stem cell transplantation (HSCT) for malignant diseases using a T-cell depletion strategy.
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
IM
pubmed:chemical
pubmed:status
MEDLINE
pubmed:month
Aug
pubmed:issn
1600-0609
pubmed:author
pubmed:copyrightInfo
© 2011 John Wiley & Sons A/S.
pubmed:issnType
Electronic
pubmed:volume
87
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
138-47
pubmed:meshHeading
pubmed-meshheading:21535161-Adolescent, pubmed-meshheading:21535161-Adult, pubmed-meshheading:21535161-Antilymphocyte Serum, pubmed-meshheading:21535161-Child, pubmed-meshheading:21535161-Child, Preschool, pubmed-meshheading:21535161-Eye Diseases, pubmed-meshheading:21535161-Female, pubmed-meshheading:21535161-Graft vs Host Disease, pubmed-meshheading:21535161-Hematopoietic Stem Cell Transplantation, pubmed-meshheading:21535161-Humans, pubmed-meshheading:21535161-Hypothyroidism, pubmed-meshheading:21535161-Immunosuppression, pubmed-meshheading:21535161-Infection, pubmed-meshheading:21535161-Lymphocyte Depletion, pubmed-meshheading:21535161-Male, pubmed-meshheading:21535161-Methylprednisolone, pubmed-meshheading:21535161-Middle Aged, pubmed-meshheading:21535161-Multivariate Analysis, pubmed-meshheading:21535161-Neoplasms, Second Primary, pubmed-meshheading:21535161-Nervous System Diseases, pubmed-meshheading:21535161-Retrospective Studies, pubmed-meshheading:21535161-Risk Factors, pubmed-meshheading:21535161-T-Lymphocytes, pubmed-meshheading:21535161-Time Factors, pubmed-meshheading:21535161-Transplantation, Homologous, pubmed-meshheading:21535161-Transplantation Conditioning, pubmed-meshheading:21535161-Treatment Outcome, pubmed-meshheading:21535161-Young Adult
pubmed:year
2011
pubmed:articleTitle
Outcome and risk factors for late-onset complications 24 months beyond allogeneic hematopoietic stem cell transplantation.
pubmed:affiliation
Division of Radiation Oncology, University Hospital, Geneva, Switzerland.
pubmed:publicationType
Journal Article